Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Brain Neoplasms/drug therapy/secondary"'
Autor:
Briassoulis, E. Ch, Samantas, E., Kalofonos, H. P., Skarlos, Dimosthenis V., Makatsoris, T., Christodoulou, C., Fountzilas, George, Bamias, A. T., Dimopoulos, M. A., Kosmidis, Paraskevas A., Pavlidis, Nicholas
Publikováno v:
Cancer chemotherapy and pharmacology
AIM: The irinotecan-cisplatin combination has emerged as a new standard for the treatment of advanced-stage small-cell lung cancer (AS-SCLC). To move forward we developed a 3-day regimen of cisplatin, etoposide and irinotecan. METHODS: Successive coh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dff2618c16a6a2974616324845805afa
https://doi.org/10.1007/s00280-004-0994-8
https://doi.org/10.1007/s00280-004-0994-8
Autor:
Kaba, S. E., Kyritsis, A. P., Hess, K., Yung, W. K., Mercier, R., Dakhil, S., Jaeckle, K. A., Levin, V. A.
PURPOSE: To evaluate a combination of thioguanine, procarbazine, dibromodulcitol, CCNU (CCNU), fluorouracil, and hydroxyurea (TPDC-FuHu), designed to improve the efficacy of CCNU, in the treatment of recurrent metastatic brain tumors. PATIENTS AND ME
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10561::7d0d27760c0850bebea6c5446b535224
http://olympias.lib.uoi.gr/jspui/handle/123456789/21098
http://olympias.lib.uoi.gr/jspui/handle/123456789/21098
